Medgenics, Inc. (the “Company”) Issue Of Options And Restricted Shares To Directors And Officers
This announcement is being made pursuant to the London Stock Exchange’s AIM Rules for Companies admitted to trading on the AIM market.
Following the award of the Restricted Shares and grant of the Options to the non-executive Directors, the interests of the directors of the Company and their related parties and other significant shareholders in the Common Shares of which the Company is aware will be as follows:
| Name | Common Shares | % of Issued Share Capital | Instrument | Number | Expiry Date | Exercise Price | Total interests | % of Issued Share Capital | ||||||||
| Isaac Blech(Director) & related parties 1 | 1,652,471 | Warrant | 230,357 | 22/9/2015 | $4.54 | |||||||||||
| Total | Warrant | 1,000,000 | 12/4/2016 | $6.00 | ||||||||||||
| Options | 19,068 | 10/12/2020 | $6.65 | |||||||||||||
| Options | 15,000 | 2/1/2022 | $2.66 | |||||||||||||
| Options | 15,000 | 2/1/2023 | $7.25 | |||||||||||||
| 7,000* | ||||||||||||||||
| 1,659,471 | 13.4% | 1,279,425 | 2,938,896 | 23.8% | ||||||||||||
| Joel S. Kanter (Director) & related parties 2 | 1,207,332 | Warrant | 26,785 | 22/9/2015 | $4.54 | |||||||||||
| Warrant | 15,540 | 12/4/2016 | $4.99 | |||||||||||||
| Options | 8,571 | 11/1/2021 | $6.55 | |||||||||||||
| Options | 28,571 | 14/9/2020 | $8.19 | |||||||||||||
| Options | 15,000 | 2/1/2022 | $2.66 | |||||||||||||
| Options | 15,000 | 2/1/2023 | $7.25 | |||||||||||||
| 7,000* | ||||||||||||||||
| Total | 1,214,332 | 9.8% | Options | 109,377 | 1,323,709 | 10.7% | ||||||||||
| Andrew L. Pearlman (Director) & related parties 4 | 35,375 | Warrant | 35,922 | 31/3/2016 | $0.0002 | |||||||||||
| Warrant | 682,240 | 31/3/2016 | $2.49 | |||||||||||||
| Options | 182,806 | 31/3/2016 | $2.49 | |||||||||||||
| Options | 80,000 | 9/12/2021 | $3.14 | |||||||||||||
| Total | 35,375 | 0.3% | 980,968 | 1,016,343 | 8.2%% | |||||||||||
| Beryl Steinberg | 621,443 | Warrant | 21,885 | 12/4/2016 | $4.99 | |||||||||||
| Total | 621,443 | 5.0% | 21,885 | 643,328 | 5.2% | |||||||||||
| Chicago Investments, Inc. 3 | 637,008 | Warrant | 5,357 | 22/9/2015 | $4.54 | |||||||||||
| Warrant | 8,368 | 12/4/2016 | $4.99 | |||||||||||||
| Total | 637,008 | 5.2% | 13,725 | 650,733 | 5.3% | |||||||||||
| Andrew Cader | 788,950 | Warrant | 264,000 | 12/4/2016 | $6.00 | |||||||||||
| Total | 788,950 | 6.4% | 264,000 | 1,052,950 | 8.5% | |||||||||||
| CIBC Trust Company (Bahamas) Limited, as Trustee of T-555 3 | 349,386 | Warrant | 10,714 | 22/9/2015 | $4.54 | |||||||||||
| Warrant | 5,150 | 12/4/2016 | $4.99 | |||||||||||||
| 349,386 | 2.8% | 15,864 | 365,250 | 3.0% | ||||||||||||
| Eugene A. Bauer (Director) | 173,017 | Options | 28,571 | 14/9/2020 | $8.19 | |||||||||||
| 42,857* | ||||||||||||||||
| Total | 215,874 | 1.7% | 28,571 | 244,445 | 2.0% | |||||||||||
| Stephen D. McMurray (Director) | 79,835 | Warrant | 644 | 12/4/2016 | $4.99 | |||||||||||
| Options | 12,857 | 11/1/2021 | $6.55 | |||||||||||||
| Options | 28,571 | 14/9/2020 | $8.19 | |||||||||||||
| Options | 15,000 | 2/1/2022 | $2.66 | |||||||||||||
| Options | 15,000 | 2/1/2023 | $7.25 | |||||||||||||
| 7,000* | ||||||||||||||||
| Total | 86,835 | 0.7% | 72,072 | 158,907 | 1.3% | |||||||||||
| Sol | Options | 900,000 | 30-6-2017 | $10.80 | ||||||||||||
| Barer (Director) | Options | 15,000 | 2/1/2023 | $7.25 | ||||||||||||
| 7,000* | ||||||||||||||||
| Total | 7,000 | 0.1% | 915,000 | 922,000 | 7.5% | |||||||||||
| Alastair Clemow (Director) | 7,000 | Options | 12,857 | 13/9/2020 | $8.19 | |||||||||||
| Options | 12,857 | 11/1/2021 | $6.55 | |||||||||||||
| Options | 15,000 | 2/1/2022 | $2.66 | |||||||||||||
| Options | 15,000 | 2/1/2023 | $7.25 | |||||||||||||
| 7,000* | ||||||||||||||||
| Total | 14,000 | 0.1% | 55,714 | 69,714 | 0.6% | |||||||||||
- Restricted shares
Notes
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
